Ozempic without insurance costs $349 per month for most doses, paid directly through Novo Nordisk’s cash-pay program or participating pharmacies. That’s a significant drop from the roughly $1,400 retail price that pharmacies historically charged, and there are several ways to bring costs down further depending on your income and which dose you need.
Current Cash Prices for Ozempic
Novo Nordisk now sells Ozempic directly to cash-paying patients at standardized prices that bypass the old, inflated retail system. The cost depends on your dose:
- 0.25 mg or 0.5 mg (starter doses): $349 per month
- 1 mg: $349 per month
- 2 mg (highest dose): $499 per month
New patients currently get an introductory offer of $199 per month for the first two fills at the 0.25 mg or 0.5 mg dose. That offer runs through June 30, 2026. You can access these prices through Ozempic.com, NovoCare, or through partners like Costco, GoodRx, WeightWatchers, Ro, LifeMD, and eMed. GoodRx coupons reflect these same price tiers, so the days of dramatically different prices across pharmacies have mostly flattened out for uninsured buyers.
Novo Nordisk’s Patient Assistance Program
If $349 a month is still out of reach, Novo Nordisk runs a Patient Assistance Program (PAP) that provides Ozempic at no cost to qualifying patients. The eligibility requirements are straightforward but strict: you must be uninsured (or on Medicare), and your total household income must fall at or below 200% of the federal poverty level. For a single person in 2025, that’s roughly $31,000 per year. For a family of four, it’s about $64,000.
If you have private or commercial insurance of any kind, you don’t qualify for the PAP, even if your plan doesn’t cover Ozempic. The program is specifically designed for people with no insurance at all or those on Medicare who can’t afford their share of the cost. You apply through NovoCare.com and will need to provide income documentation.
Telehealth Providers and What They Charge
Several telehealth companies now offer Ozempic prescriptions bundled with virtual consultations, which eliminates the cost of an in-person doctor visit. The total you pay typically includes a monthly membership fee plus the medication itself. Here’s what the major platforms charge:
- Ro: $145 per month membership, plus the cost of Ozempic through the Novo Nordisk cash-pay program
- Hims & Hers: $149 per month ($39 for the first month), with injectable Wegovy (same active ingredient as Ozempic, approved for weight loss) at $199 per month
- WeightWatchers Clinic: $74 per month with a 12-month commitment, with Wegovy starting at $199 per month
- Mochi Health: $79 per month membership
The membership fees cover consultations, dosage adjustments, and ongoing monitoring. Some platforms prescribe brand-name Ozempic or Wegovy at the standard Novo Nordisk cash price, while others offer compounded versions of semaglutide at lower prices. That distinction matters, and it’s worth understanding the tradeoffs before choosing a provider.
Compounded Semaglutide: Lower Cost, Higher Risk
Some telehealth platforms and compounding pharmacies sell compounded semaglutide for less than brand-name Ozempic. Mochi Health, for example, lists compounded semaglutide at $99 per month. Remedy Meds charges $299. Henry Meds starts at $179. These are meaningful savings compared to $349 for the brand-name version.
But compounded drugs are not FDA-approved, meaning no federal agency checks their safety, effectiveness, or quality before they reach you. The FDA has flagged several specific problems with compounded semaglutide products. Some have arrived warm during shipping, with inadequate cold packs to maintain proper storage temperatures. Others contained semaglutide salt forms (like semaglutide sodium or semaglutide acetate) that are chemically different from the active ingredient in approved Ozempic, and the FDA says it has no information on whether these salts behave the same way in your body.
Dosing errors are another real concern. The FDA has received multiple reports of hospitalizations tied to patients measuring incorrect doses of compounded injectable semaglutide. Unlike the pre-filled Ozempic pen, which clicks to deliver a precise dose, compounded injectables often require you to draw up your own dose from a vial. Some health care providers have also miscalculated doses when prescribing compounded products. The FDA has also identified outright fraudulent products with fake pharmacy names on the labels.
If you go this route, verify that the compounding pharmacy is licensed in your state and registered with the FDA. Ask whether the product uses the same form of semaglutide as the approved drug, not a salt form.
Buying From International Pharmacies
Ozempic is available in many countries at lower prices, which leads some people to look into ordering from Canadian or overseas pharmacies. In most circumstances, importing prescription drugs into the U.S. for personal use is illegal, even if the drug is approved and widely used in the country you’re buying from. The FDA’s position is clear: if a drug hasn’t gone through U.S. approval for that specific source, importing it violates federal law.
Beyond the legal issue, the FDA warns it cannot verify the safety or effectiveness of medications purchased from foreign sources, whether online, through a storefront broker, or during travel. Counterfeit versions of popular drugs like Ozempic may contain the wrong amount of active ingredient, no active ingredient at all, or harmful additives. The agency can refuse entry of any product that appears to pose a serious health risk.
When Generic Ozempic Might Be Available
Novo Nordisk’s U.S. patent on semaglutide is set to expire in 2032. In October 2024, the company reached settlements with several major generic manufacturers, which likely include agreed-upon dates for generic versions to enter the market. The specific terms remain confidential, but settlements like these typically allow generics to launch before the patent fully expires, sometimes by a few years.
Novo Nordisk’s patents in other countries expire sooner, which means generic semaglutide could appear internationally before it reaches U.S. pharmacies. For now, the earliest realistic window for a generic in the U.S. is somewhere around 2030 to 2032, though the settlement terms could shift that timeline.
Practical Steps to Start
Your most direct path depends on your income. If your household income falls below 200% of the federal poverty level, apply for the Patient Assistance Program through NovoCare first. It’s free medication, and the application process is straightforward.
If you earn too much for the PAP, the $349 per month cash price through Novo Nordisk’s direct channels is currently the most reliable option for brand-name Ozempic. Use the $199 introductory offer for your first two months at the starter dose. You’ll need a prescription, which you can get from your primary care doctor or through a telehealth platform. Factor in the telehealth membership fee when comparing total costs, since some platforms charge $79 to $149 per month on top of the medication price.
Compounded semaglutide offers the lowest total cost but comes with tradeoffs in quality assurance and dosing precision that are worth weighing carefully, especially for a medication you’ll use long-term.